The activation of STAT3 by IL-6 contributes to joint destruction in RA by promoting the upregulation of receptor activator of nuclear factor kappa-B ligand (RANKL) in osteoblasts and facilitating the differentiation of osteoclasts (25). Here, IL6 is linked to rheumatoid arthritis.